UiPath Inc. stocks have been trading down by -11.91 percent amid bearish sentiment over automation demand and growth sustainability. Key Takeaways UiPath CEO and major insider Daniel Dines sold about 1.4 million shares, worth roughly $22.5M. Despite this sale, Dines still controls approximately 26.5 million Class A shares of UiPath. The transaction highlights both profit-taking…

UiPath, Inc. stock analysis reveals a strong daily uptrend with post-earnings momentum pause. Get key levels, earnings impact, and trend insights.

BMO Capital Markets boosted their price target on shares of UiPath from $13.00 to $18.00 and gave the stock a "market perform" rating in a research report on Friday.

Northwestern Mutual Wealth Management Co. lifted its position in UiPath, Inc. (NYSE:PATH - Free Report) by 48.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 303,584 shares of the company

Revenue of $410 million increased 13 percent year-over-year ARR of $1.938 billion increased 12 percent year-over-year GAAP operating income…...

Hitesh Ramani Promoted to Chief Financial Officer Ashim Gupta to Continue as Chief Operating Officer Brad Brubaker Named Chief Legal &…...

UiPath, Inc. has been downgraded due to its valuation no longer supporting a bullish outlook, despite demonstrating strong cost control and operational efficiency. The company's revenue growth remains steady at 12%, but it lacks the rapid acceleration seen in AI-driven software companies, raising concerns about potential disruption from AI advancements. While UiPath boasts excellent incremental operating margins and a net cash balance sheet, its modest top-line growth and current valuation multiples (21x earnings, 5x sales) suggest limited near-term upside. Investors should weigh these factors carefully when considering UiPath's stock in the context of AI market dynamics.

UiPath downgrade: strong margins and net cash, but 12% growth lags AI peers; valuation looks fair amid AI disruption risk. See more on PATH stock here.